Keratoconjunctivitis, Vernal: Clinical Trials

1 trial for Keratoconjunctivitis, Vernal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Keratoconjunctivitis, Vernal: new trials by email Literature Review of Keratoconjunctivitis, Vernal trials Research Report on Keratoconjunctivitis, Vernal

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Clinical and Biological Efficacity of NAAXIA SINEĀ® in Vernal Keratoconjunctivitis
N-acetyl-aspartyl-glutamate (NAAXIA Sine) - Keratoconjunctivitis, Vernal
Phase 4CompletedLaboratoires Thea2001-04-012006-07-27

Narrower conditions

Conjunctivitis, Allergic (1)

Broader conditions

Conjunctival Diseases (1)  ·  Conjunctivitis (1)  ·  Eye Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)

Interventions

isospaglumic acid (1)

Sponsors

Laboratoires Thea (1)

Results publications

PMID 17585003